Register
Community
Overview
Experts
Editors
Fellows
Code of conduct
Company
About Us
FAQs
Privacy Policy
Terms of Use
Careers
Programs
News
News Releases
Press Coverage
Publications
Blog
Contact Us
Sign in
Please select the option that best describes you:
Topics:
Psychiatry
•
Neuromodulation
•
Ketamine
How do you determine the treatment course of esketamine or IV ketamine when used for treatment resistant MDD?
Related Questions
How do you approach tapering electroconvulsive therapy after an acute treatment course leading to successful resolution of symptoms for treatment-resistant depression?
How do you manage stroke-related abulia?
When do you decide to use liothyronine (T3) for augmentation in treatment for treatment-resistant depression and how do you implement it?
When do you select cholinesterase inhibitors vs NMDA-antagonist medications in patients with moderate Alzheimer’s dementia?
Do you warn patients about suicidal ideation when starting anti-seizure medications?
How do you titrate lithium for patients with bipolar affective disorder during pregnancy and immediately after delivery in the context of fluid shifts and changing levels?
In what cases do you recommend the use of gabapentin for off-label use in alcohol use disorder?
How do you counsel patients on vaping cessation as compared to smoking cessation?
Without any symptoms of drug-induced hyperprolactinemia, do you still consider changing atypical antipsychotics (that are working very well) if the prolactin levels are high in children undergoing puberty?
How do you address mental health and online presence with teenage patients?
